
Helping sponsors design effective oversight.
Staying informed is not the same as having oversight.
The study update looks reassuring. But how much confidence should you place in it?
A recurring site issue may appear manageable in each report. Viewed across the trial, it may warrant a different response. An action can be closed while the concern that prompted it remains unresolved.
The gap sits between receiving information and having enough evidence to make a sound decision.
For a lean sponsor team, that gap has practical consequences. Time goes into chasing detail. Decisions wait for clarity. Issues can absorb more attention than they would have needed earlier.
Effective oversight helps you see where to look more closely and judge whether the response is sufficient. It also gives you a basis for leaving a working approach in place.
Silvertree BioLife helps you build that clarity through Oversight Design, Oversight Gap Analysis, and Targeted Quality Reviews.
Know what deserves your attention. Have a defensible basis for what you do next.
Start with the decisions your team needs to make. Build oversight that supports them.
Every sponsor operates with a different mix of internal expertise, service providers, and study demands. Your oversight approach needs to work within that reality.
Silvertree examines how trial information reaches your team and what happens next. Where does responsibility sit? What prompts closer review? How do you know an agreed action has addressed the concern?
We use that understanding to help you establish oversight before a study begins or strengthen the model already in place. When a specific concern needs closer examination, we focus the review on the question you need answered.
Recommendations reflect your study’s risks and the resources available to act on them, with clear priorities your team can put into practice.
A workable approach. A clearer basis for decisions.
The right starting point depends on whether you are building an oversight approach, assessing the current model, or examining a specific area of concern.
Establish a practical oversight approach before study execution, with clear responsibilities, governance arrangements, and escalation pathways.
Assess how your current oversight model is designed and operates in practice, identifying strengths and priority areas for improvement.
Examine a specific site, vendor, process, or area of trial conduct where closer review is needed.
From planning through execution, sponsor oversight needs to be deliberate, visible, and accountable.
Silvertree BioLife
SPONSOR OVERSIGHT | CLINICAL TRIAL GOVERNANCE